3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Mucositis
1
Esophagitis
1
Breast Neoplasms
1
Interventions
Cisplatin
4
angiotensin I (1-7)
3
Radiotherapy
3
Radiation
3
Injections
3
Water
2
RRx-001
2
Interleukin 1 Receptor Antagonist Protein
2
Drug Therapy
2
Amifostine
2
tempol
1
peppermint oil
1
pegfilgrastim
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
glucarpidase
1
fish oil triglycerides
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Xylitol
1
Vaccinium myrtillus extract
1
Tramadol
1
Therapeutics
1
Surgical Procedures, Operative
1
Sorbic Acid
1
Sodium Bicarbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mucositis
×
Alginates
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled